Epitel

Medical-grade EEG at home, with compact wireless sensors for comfortable, continuous brain monitoring

Description

Seizures can be unpredictable, making them difficult to capture during short clinical assessments. Epitel equips neurology clinics with its REMI system, a compact, wireless EEG platform that enables extended monitoring at home. FDA-cleared for adults and children aged one year and older, the system records brain activity as patients follow their everyday routines. Clinicians can review recordings remotely, with AI tools helping flag potential seizure events for interpretation. This gives clinicians more opportunity to capture the events needed to inform diagnosis and treatment, while making monitoring more comfortable for patients

Product

No items found.

Our Investment Thesis

  • Underserved Market Opportunity: Epitel addresses practical barriers to ambulatory EEG, including cumbersome equipment, patient discomfort and limited access to testing. Its portable system can serve existing demand while enabling more clinics to offer extended monitoring, with opportunities to reach additional patients and expand into new clinical applications.
  • Proprietary Technology: Compact EEG sensors and proprietary hydrogel stickers enable comfortable, extended monitoring. Data captured in everyday settings provides a foundation for enhancing AI and developing predictive capabilities.
  • Strong Commercial Foundations: Multiple FDA clearances, a substantial patent portfolio and established reimbursement support a differentiated, revenue-generating platform, backed by an experienced technical and commercial team.

CEO

Steve Pacelli

Location

San Diego, USA

Website

Visit Site

Theme

#PreventiveCare
#SelfCare
#SmartHospital